Andy Murray

Andy Murray has a diverse work experience in various research and leadership roles. Andy is currently the CEO and Founder of Sania Therapeutics since April 2021. In addition, they hold the position of Honorary Senior Research Fellow at UCL starting from January 2023. Previously, they served as a Group Leader in Neuroscience at the Sainsbury Wellcome Centre for Neural Circuits and Behaviour from January 2016 to January 2023. Prior to that, they worked as an Associate Research Scientist at Columbia University Medical Center from September 2010 to December 2015.

Andy Murray completed a Doctor of Philosophy (PhD) in Neuroscience from the University of Aberdeen, where they attended from 2004 to 2007. In addition to their academic achievements, they also obtained certifications in Managerial Finance from The London School of Economics and Political Science (LSE) in February 2023, and in Brad Feld on Raising Capital from LinkedIn in September 2020.